Cargando…

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles

High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced ather...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Shahan, Nissilä, Eija, Ruhanen, Hanna, Fudo, Satoshi, Gaytán, Meztlli O., Sihvo, Sanna P., Lorey, Martina B., Metso, Jari, Öörni, Katariina, King, Samantha J., Oommen, Oommen P., Jauhiainen, Matti, Meri, Seppo, Käkelä, Reijo, Haapasalo, Karita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175417/
https://www.ncbi.nlm.nih.gov/pubmed/34124613
http://dx.doi.org/10.1016/j.isci.2021.102535
Descripción
Sumario:High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression.